Keybank National Association OH Sells 3,061 Shares of Cigna Group $CI

Keybank National Association OH trimmed its holdings in shares of Cigna Group (NYSE:CI) by 2.3% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 128,435 shares of the health services provider’s stock after selling 3,061 shares during the period. Keybank National Association OH’s holdings in Cigna Group were worth $35,349,000 as of its most recent filing with the SEC.

A number of other large investors also recently modified their holdings of the company. Vanguard Group Inc. lifted its holdings in shares of Cigna Group by 1.6% in the 4th quarter. Vanguard Group Inc. now owns 26,173,577 shares of the health services provider’s stock worth $7,203,754,000 after purchasing an additional 414,834 shares in the last quarter. Massachusetts Financial Services Co. MA lifted its holdings in shares of Cigna Group by 8.3% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 11,805,083 shares of the health services provider’s stock worth $3,249,113,000 after purchasing an additional 903,334 shares in the last quarter. Dodge & Cox lifted its holdings in shares of Cigna Group by 4.0% in the 3rd quarter. Dodge & Cox now owns 9,305,225 shares of the health services provider’s stock worth $2,682,231,000 after purchasing an additional 354,615 shares in the last quarter. Sanders Capital LLC lifted its holdings in shares of Cigna Group by 0.5% in the 3rd quarter. Sanders Capital LLC now owns 7,828,168 shares of the health services provider’s stock worth $2,256,469,000 after purchasing an additional 35,150 shares in the last quarter. Finally, Capital Research Global Investors lifted its holdings in shares of Cigna Group by 140.2% in the 3rd quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider’s stock worth $916,434,000 after purchasing an additional 1,855,897 shares in the last quarter. 86.99% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 2,307 shares of the firm’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $666,515.37. Following the transaction, the insider directly owned 32,647 shares in the company, valued at approximately $9,432,044.77. This trade represents a 6.60% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Everett Neville sold 1,719 shares of the firm’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $496,636.29. Following the sale, the insider directly owned 5,670 shares of the company’s stock, valued at approximately $1,638,119.70. This represents a 23.26% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.60% of the stock is currently owned by company insiders.

Analyst Ratings Changes

CI has been the topic of a number of recent research reports. Leerink Partners increased their target price on Cigna Group from $270.00 to $297.00 and gave the stock a “market perform” rating in a report on Friday, February 6th. Deutsche Bank Aktiengesellschaft increased their target price on Cigna Group from $301.00 to $304.00 and gave the stock a “buy” rating in a report on Tuesday, February 10th. UBS Group reiterated a “buy” rating and issued a $375.00 target price on shares of Cigna Group in a report on Monday, February 9th. TD Cowen increased their target price on Cigna Group from $333.00 to $338.00 and gave the stock a “buy” rating in a report on Monday, February 9th. Finally, Jefferies Financial Group cut their target price on Cigna Group from $333.00 to $330.00 and set a “buy” rating on the stock in a report on Monday, April 20th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $332.47.

Cigna Group Price Performance

Shares of NYSE:CI opened at $292.16 on Thursday. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.74. The stock’s fifty day simple moving average is $274.24 and its two-hundred day simple moving average is $276.84. Cigna Group has a 1-year low of $239.51 and a 1-year high of $350.00. The stock has a market cap of $76.99 billion, a PE ratio of 13.17, a price-to-earnings-growth ratio of 0.98 and a beta of 0.26.

Cigna Group (NYSE:CI) last issued its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, beating the consensus estimate of $7.88 by $0.20. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The business had revenue of $72.50 billion for the quarter, compared to analysts’ expectations of $69.53 billion. During the same period last year, the business earned $6.64 EPS. The business’s revenue was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. As a group, analysts forecast that Cigna Group will post 30.32 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be paid a dividend of $1.56 per share. The ex-dividend date is Thursday, June 4th. This represents a $6.24 annualized dividend and a yield of 2.1%. Cigna Group’s dividend payout ratio (DPR) is 28.13%.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.